D-0346-2019 Class II Terminated

Recalled by LUPIN SOMERSET — Somerset, NJ

FDA drug recall D-0346-2019 was initiated by LUPIN SOMERSET on Dec 21, 2018 and is designated Class II. Reason for recall: Subpotent Drug: Expansion of June 2018 recall of lots S700065 and S700619 due to below specification results for assay. The recall status is terminated (terminated Mar 15, 2023). Affected quantity: 23,460 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 9, 2019
Initiation Date
Dec 21, 2018
Termination Date
Mar 15, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
23,460 bottles

Product description

Nitrofurantoin Oral Suspension, USP, 25mg/5mL, 230 mL bottle, Rx only, Manufactured by: Novel Laboratories, Inc., Somerset, NJ 08873; Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202, NDC 43386-450-11.

Reason for recall

Subpotent Drug: Expansion of June 2018 recall of lots S700065 and S700619 due to below specification results for assay.

Distribution pattern

Nationwide in the USA and Puerto Rico.

Code information

Lot #: S700038, S700044, S700059, S700065, Exp 28-Feb-19; S700410, S700427, Exp 30-Jun-19; S700617, S700619, Exp 31-Aug-19; S700813, S700815, S700869, Exp 31-Oct-19; S700871, S700873, Exp 30-Nov-19; S700875, S701073, Exp 31-Dec-19.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0346-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0346-2019. Report a data issue: hello@regdatalab.com.